API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215762
https://www.globenewswire.com//news-release/2023/12/19/2798587/0/en/Scilex-Holding-Company-Announces-Results-from-Market-Research-with-Rheumatologists-Reveal-a-High-Degree-of-Interest-in-Gloperba-as-a-Liquid-Colchicine-Formulation-Designed-for-Prec.html
https://www.fiercepharma.com/pharma/takeda-settles-pay-delay-lawsuit-over-gout-drug-colcrys
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212880
https://www.businesswire.com/news/home/20230620113838/en/U.S.-FDA-Approves-First-Anti-Inflammatory-Drug-for-Cardiovascular-Disease
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2023-25079.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215762
https://www.escardio.org/The-ESC/Press-Office/Press-releases/COVID-19-inpatients-do-not-gain-from-aspirin-and-rivaroxaban-combined-or-colchicine-alone
https://www.escardio.org/The-ESC/Press-Office/Press-releases/COVID-19-patients-in-the-community-do-not-benefit-from-colchicine-or-aspirin
https://medicaldialogues.in/news/industry/medical-devices/usfda-asks-philips-respironics-to-notify-patients-about-ventilator-recall-89826?infinitescroll=1
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209173
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215444
https://www.newswire.ca/news-releases/pharmascience-introduces-myinfla-tm-colchicine-0-5-mg-extended-release-tablets-a-new-repurposed-treatment-now-available-in-canada-to-reduce-the-risk-of-cardiovascular-disease-872812988.html
https://www.globenewswire.com/news-release/2021/08/27/2287639/0/en/Health-Canada-approval-of-low-dose-colchicine-for-cardiovascular-disease-based-on-the-COLCOT-study.html
https://endpts.com/covid-19-roundup-controversy-around-colchicine-percolates-after-study-failure-astrazenecas-meeting-with-eu-was-constructive-but-didnt-solve-much/
https://www.globenewswire.com/news-release/2021/01/23/2163109/0/en/Colchicine-reduces-the-risk-of-COVID-19-related-complications.html#:~:text=The%20study%20results%20have%20shown,COVID%2D19%20compared%20to%20placebo.&text=In%20these%20patients%20with%20a,%2C%20and%20deaths%20by%2044%25.
https://www.globenewswire.com/news-release/2020/11/29/2135655/0/en/Colchicine-shows-promise-as-a-treatment-for-at-home-COVID-19-patients.html
https://www.biospace.com/article/releases/pharmascience-inc-reiterates-its-support-to-the-montreal-heart-institute-s-colchicine-repurposing-research-studies-in-cardiovascular-medicine-and-covid-19/
https://news.bloomberglaw.com/ip-law/takeda-loses-appellate-bid-to-bar-copycats-of-colcrys-gout-drug
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-gloperba-210942colchicine-oral-solution-06-mg5-ml-1590042988.pdf
https://www.techtimes.com/articles/249008/20200420/anti-covid-19-drug-new-trial-of-anti-inflammatory-drug-colchicine-can-this-preven-coronovirus-complications.htm
https://www.prnewswire.com/news-releases/avion-pharmaceuticals-new-gout-prophylaxis-product-gloperba-is-the-first-and-only-liquid-form-of-colchicine-1-2-301012641.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-colcrys-22352colchicine-for-tablets-03-mg-1566279179.pdf
https://www.businesswire.com/news/home/20190226005274/en/ROMEG-Therapeutics-Receives-FDA-Approval-GLOPERBA%C2%AE-colchicine/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208678
https://www.pharmacompass.com/pdf/news/recipharm-ltd-fails-edqm-inspection-1540034321.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211519
https://www.pharmacompass.com/pdf/news/colcrys-colchicine-usp-takeda-pharmaceuticals-v-alkem-laboratories-1517810817.pdf
https://www.pharmacompass.com/pdf/news/mitigare-colchicine-west-ward-pharma-corp-v-granules-pharmaceuticals-usa-1517214884.pdf
http://www.thehindubusinessline.com/companies/article9818570.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2016/01/briefing-in-appeal-over-colchicine-505b2-approval-wraps-up-oral-argument-and-a-decision-are-patientl.html
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11969525/Hikma-lowers-guidance-after-gout-drug-fails-to-take-off.html
http://blogs.wsj.com/pharmalot/2015/05/05/how-marketing-exclusivity-led-to-higher-drug-costs-and-questionable-benefits/
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.fiercepharmaasia.com/story/japan-mhlw-panel-names-11-unapprovedoff-label-drugs-fast-track-reviews/2015-04-27
http://www.fiercepharma.com/story/otsuka-scrambles-persuade-judge-block-abilify-copycats/2015-04-16
http://www.fiercepharma.com/story/study-says-no-good-has-come-fdas-action-gout-drug-colchicine/2015-04-10
http://www.reuters.com/article/2015/02/24/us-cymabay-urgent-idUSKBN0LS11Y20150224
http://www.fiercepharma.com/story/mylan-said-be-eyeing-7b-plus-bid-rising-star-hikma/2015-01-28
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/district-court-tackles-sticky-505b2-application-issues-in-an-extensive-memorandum-opinion-involving-.html
http://connect.dcat.org/blogs/pharma-news/2015/01/15/takeda-plans-appeal-in-patent-litigation#.VLijKtKUde8
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/district-court-sides-with-fda-505b2-applicant-in-challenge-to-colchicine-capsules-approval-an-appeal.html
http://seattletimes.com/html/health/2025372239_pharmacy11xml.html